Bailey Glasser has amassed considerable experience representing clients involved in the cannabis industry. Our firm’s client roster includes producers, investors, and distributors with operations in various states. We have also represented supply-side companies selling goods and services to cannabis suppliers in other states.
We provide general legal services to these businesses in addition to counseling them on compliance with the applicable states’ regulatory programs. Additionally, we assist clients in securing necessary licenses in order to operate in order to pursue cannabis related business opportunities.
Bailey Glasser is also advising clients on the complicated and ever-changing interplay between state laws that permit cannabis production and distribution and potential enforcement of federal laws such as the Bank Secrecy Act (BSA) and the Controlled Substances Act (CSA) under which cannabis is classified as a prohibited Schedule I narcotic. This interdisciplinary team of lawyers are leading authorities in the regulatory and political landscape surrounding legal cannabis, including the two “Cole” memos setting forth enforcement priorities of the US Department of Justice (DOJ) and guidance by the Financial Crimes Enforcement Network (FinCEN) issued concurrently with the second Cole memo.
Moreover, our team of lawyers track new federal rules and regulations applicable to cannabis, such as the Hemp Farming Act which removes hemp-derived products, such as CBD, from Schedule I classification under the CSA and H.R. 1595, the Secure and Fair Enforcement (SAFE) Banking Act that would align federal and state laws and prohibit federal agencies from taking certain adverse actions against financial institutions banking cannabis businesses.
- Of Counsel